High-priced antiretroviral drugs can slow AIDS, but unregulated production of generic versions challenges the international principle of intellectual-property protection.
The economic impact of medications is noteworthy, with many countries not being able to bear the cost of essential medicines recommended by the World Health Organization (WHO).
Generic medications offer an approach that seeks to address this issue. Generic medicines bear a resemblance to but are not the same as originator medications.
They have a pronounced cost benefit since they do not require the background research and development studies to support registration.
However, the use of generic medicines puts down great pressure on the research and development-driven pharmaceutical industry, upon which we depend for developing drugs of the future.
To learn more about Generic medications here
https://brainly.com/question/9526183
#SPJ4
